» Articles » PMID: 21499809

Risk Factors That Influence Early Death Due to Cancer Recurrence After Extended Radical Esophagectomy with Three-field Lymph Node Dissection

Overview
Journal Ann Surg Oncol
Publisher Springer
Specialty Oncology
Date 2011 Apr 19
PMID 21499809
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Extended radical esophagectomy with three-field lymph node dissection (3-FLD) has offered significant survival benefit, but some patients still suffer from early recurrence and die within 1 year after surgery. The purpose of this study was to identify the risk factors that influence early death due to cancer recurrence after extended radical esophagectomy with 3-FLD.

Methods: A consecutive series of 276 patients who underwent extended radical esophagectomy with 3-FLD was retrospectively reviewed. Excluding patients who underwent incomplete resection or died of other diseases within 1 year, we compared the clinicopathological characteristics between 203 patients who survived more than 1 year (1-year survival group) and 27 who died of cancer recurrence within 1 year (early-death group) by univariate and multivariate analysis.

Results: Sixty-six patients (32.5%) had recurrent disease in the 1-year survival group. Hematogenous recurrences were more frequent in the early-death group than in the 1-year survival group (41% vs. 26%, respectively, p = 0.0481). There was a significant difference in nodal status, number of metastatic nodes, pathological stage, vessel invasion, and intramural metastasis, and there was borderline significance in the difference of depth of invasion and histological type between the two groups by univariate analysis. Multivariate analysis demonstrated that intramural metastasis was an independent risk factor.

Conclusions: Patients with intramural metastasis have a significant risk of early death even after extended radical esophagectomy with 3-FLD; however, it remains unknown whether surgical intervention can play a significant role for these patients.

Citing Articles

The impact of time to postoperative recurrence on the prognosis of patients with esophageal cancer post recurrence: exploratory analysis of OGSG 1003.

Hori S, Yamasaki M, Yamamoto N, Harino T, Momose K, Yamashita K Esophagus. 2024; 21(4):472-483.

PMID: 39174706 DOI: 10.1007/s10388-024-01070-y.


Impact of quality of life on mortality risk in patients with esophageal cancer: a systematic review and meta-analysis.

Inoue J, Morishita S, Okayama T, Suzuki K, Tanaka T, Nakano J Esophagus. 2024; 21(3):270-282.

PMID: 38772959 DOI: 10.1007/s10388-024-01064-w.


Systemic inflammation score as a predictor of death within one year after esophagectomy.

Sato S, Nakatani E, Hawke P, Nagai E, Taki Y, Nishida M Esophagus. 2024; 21(3):336-347.

PMID: 38625663 DOI: 10.1007/s10388-024-01059-7.


The treatment efficacy and prognosis of each treatment in early postoperative recurrence of esophageal squamous cell carcinoma.

Ohsawa M, Hamai Y, Emi M, Ibuki Y, Kurokawa T, Yoshikawa T Surg Today. 2023; 54(1):53-63.

PMID: 37225930 DOI: 10.1007/s00595-023-02702-z.


Clinical predictors of early postoperative recurrence after radical esophagectomy for thoracic esophageal cancer.

Matsui K, Kawakubo H, Matsuda S, Hirata Y, Irino T, Fukuda K Esophagus. 2023; 20(4):679-690.

PMID: 37222963 DOI: 10.1007/s10388-023-01014-y.